During the past decade, Dept Geriatric and Metabolic diseases SUN conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Dept Geriatric and Metabolic diseases SUN" are "Apical Ballooning Syndrome" (1 trials), "Nervous System Diseases, Sympathetic" (1 trials), "Restenosis" (1 trials) and "Tight Glycemic Control" (1 trials). Many other conditions were trialed in "Dept Geriatric and Metabolic diseases SUN" in a lesser frequency.

Most popular intervention types in "Dept Geriatric and Metabolic diseases SUN" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin" (1 trials), "L-acetyl carnitine" (1 trials), "Placebo" (1 trials) and "alpha-lipoic acid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dept Geriatric and Metabolic diseases SUN" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Dept Geriatric and Metabolic diseases SUN". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Dept Geriatric and Metabolic diseases SUN, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dept Geriatric and Metabolic diseases SUN, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".